Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Net Margin (2018 - 2025)

TransMedics (TMDX) has 8 years of Net Margin data on record, last reported at 42.35% in Q4 2025.

  • For Q4 2025, Net Margin fell 1896.0% year-over-year to 42.35%; the TTM value through Dec 2025 reached 2.12%, up 209.0%, while the annual FY2025 figure was 31.24%, 3121.0% up from the prior year.
  • Net Margin reached 42.35% in Q4 2025 per TMDX's latest filing, down from 13.77% in the prior quarter.
  • Across five years, Net Margin topped out at 94.65% in Q4 2022 and bottomed at 239.46% in Q3 2021.
  • Average Net Margin over 5 years is 32.32%, with a median of 14.87% recorded in 2023.
  • Peak YoY movement for Net Margin: crashed -16771bps in 2021, then surged 22568bps in 2022.
  • A 5-year view of Net Margin shows it stood at 131.03% in 2021, then surged by 172bps to 94.65% in 2022, then tumbled by -59bps to 38.34% in 2023, then plummeted by -161bps to 23.39% in 2024, then tumbled by -81bps to 42.35% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 42.35% in Q4 2025, 13.77% in Q3 2025, and 21.03% in Q2 2025.